Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms
Patterns & Phenotypes
Differential expression and regulation by activin of the neurotrophins BDNF and NT4 during human and mouse ovarian development†
Article first published online: 19 FEB 2010
Copyright © 2010 Wiley-Liss, Inc.
Volume 239, Issue 4, pages 1211–1219, April 2010
How to Cite
Childs, A. J., Bayne, R. A.L., Murray, A. A., Martins Da Silva, S. J., Collins, C. S., Spears, N. and Anderson, R. A. (2010), Differential expression and regulation by activin of the neurotrophins BDNF and NT4 during human and mouse ovarian development. Dev. Dyn., 239: 1211–1219. doi: 10.1002/dvdy.22252
- Issue published online: 16 MAR 2010
- Article first published online: 19 FEB 2010
- Manuscript Accepted: 18 JAN 2010
- Medical Research Council. Grant Numbers: WBS U.1276.00.002.00001, G0400868
- primordial follicle;
The tropomyosin-related kinase (Trk) B neurotrophin receptor is essential for ovarian germ cell survival and primordial follicle formation, but the contributions of its ligands, brain-derived neurotrophic factor (BDNF) and neurotrophin-4 (NT4), are unknown. We have investigated their expression and regulation in developing human and mouse ovaries. BDNF expression increased with increasing gestation, expression of human NTF4 and of both Ntf5 and Bdnf in the mouse was unchanged. Bdnf expression was dramatically lower than Ntf5 in the mouse, but levels were comparable in the human. Human fetal ovarian somatic cells expressed BDNF. Activin A selectively regulated BDNF and Ntf5 expression in human and mouse, respectively, identifying an oocyte/somatic signaling pathway which might mediate the pro-survival effects of activin. These data reveal that expression and regulation of the TrkB ligands are differentially controlled in the developing ovaries of humans and mice, and identify BDNF as a potential regulator of germ cell fate in the human fetal ovary. Developmental Dynamics 239:1211–1219, 2010. © 2010 Wiley-Liss, Inc.